XML 28 R19.htm IDEA: XBRL DOCUMENT
v3.22.4

Capital Stock | 9 Months Ended
--- | ---
Dec. 31, 2022
Equity and Share-based Compensation [Abstract] |
Capital Stock | Capital Stock (a) Common Shares The Company had 500 million authorized Class A voting shares and 500 million authorized Class B non-voting shares at December 31, 2022 and March 31, 2022. The table below outlines common shares reserved for future issuance:
| December 31, 2022 |  | March 31, 2022
| (Amounts in millions)
Stock options and share appreciation rights (SARs) outstanding | 24.9 |  |  | 27.6 |
Restricted stock and restricted share units — unvested | 14.5 |  |  | 7.9 |
Common shares available for future issuance | 11.1 |  |  | 18.4 |
Shares reserved for future issuance | 50.5 |  |  | 53.9 |
(b) Share-based Compensation The Company recognized the following share-based compensation expense during the three and nine months ended December 31, 2022 and 2021:
| Three Months Ended |  | Nine Months Ended
| December 31, |  | December 31,
| 2022 |  | 2021 |  | 2022 |  | 2021
| (Amounts in millions)
Compensation Expense: |  |  |  |  |  |  |
Stock options | $ | 1.5 |  |  | $ | 4.1 |  |  | $ | 5.6 |  |  | $ | 15.6 |
Restricted share units and other share-based compensation | 20.8 |  |  | 16.4 |  |  | 49.7 |  |  | 56.4 |
Share appreciation rights | 1.0 |  |  | 2.1 |  |  | 2.4 |  |  | 5.5 |
| 23.3 |  |  | 22.6 |  |  | 57.7 |  |  | 77.5 |
Impact of accelerated vesting on equity awards(1) | 1.5 |  |  | — |  |  | 2.1 |  |  | — |
Total share-based compensation expense | $ | 24.8 |  |  | $ | 22.6 |  |  | $ | 59.8 |  |  | $ | 77.5 |
Tax impact(2) | (4.1) |  |  | (4.4) |  |  | (10.4) |  |  | (15.3) |
Increase in net loss or reduction in net income | $ | 20.7 |  |  | $ | 18.2 |  |  | $ | 49.4 |  |  | $ | 62.2 |
___________________ (1)Represents the impact of the acceleration of certain vesting schedules for equity awards pursuant to certain severance arrangements. (2)Represents the income tax benefit recognized in the unaudited condensed consolidated statements of operations for share-based compensation arrangements prior to the effects of changes in the valuation allowance. Share-based compensation expense, by expense category, consisted of the following:
| Three Months Ended |  | Nine Months Ended
| December 31, |  | December 31,
| 2022 |  | 2021 |  | 2022 |  | 2021
| (Amounts in millions)
Share-Based Compensation Expense: |  |  |  |  |  |  |
Direct operating | $ | 0.5 |  |  | $ | 0.4 |  |  | $ | 1.2 |  |  | $ | 0.9 |
Distribution and marketing | 0.2 |  |  | 0.2 |  |  | 0.6 |  |  | 0.5 |
General and administration | 22.6 |  |  | 22.0 |  |  | 55.9 |  |  | 76.1 |
Restructuring and other | 1.5 |  |  | — |  |  | 2.1 |  |  | — |
| $ | 24.8 |  |  | $ | 22.6 |  |  | $ | 59.8 |  |  | $ | 77.5 |
The following table sets forth the stock option, SARs, restricted stock and restricted share unit activity during the nine months ended December 31, 2022:
| Stock Options and SARs |  | Restricted Stock and Restricted Share Units
| Class A Voting Shares |  | Class B Non-Voting Shares |  | Class A Voting Shares |  | Class B Non-Voting Shares
| Number of Shares |  | Weighted-Average Exercise Price |  | Number of Shares |  | Weighted-Average Exercise Price |  | Number of Shares |  | Weighted-Average Grant-Date Fair Value |  | Number of Shares |  | Weighted-Average Grant-Date Fair Value
| (Number of shares in millions)
Outstanding at March 31, 2022 | 5.4 |  |  | $24.34 |  | 22.2 |  |  | $15.36 |  | — |  | (1) | $11.51 |  | 7.9 |  |  | $11.87
Granted | — |  |  | — |  |  | 0.3 |  |  | $8.97 |  | — |  | (1) | $10.27 |  | 11.9 |  |  | $9.02
Options exercised or restricted stock or RSUs vested | — |  | (1) | $7.70 |  | (0.4) |  |  | $10.17 |  | — |  | (1) | $11.19 |  | (5.0) |  |  | $11.99
Forfeited or expired | (1.1) |  |  | $16.58 |  | (1.5) |  |  | $17.21 |  | — |  |  | — |  |  | (0.3) |  |  | $10.59
Outstanding at December 31, 2022 | 4.3 |  |  | $26.31 |  | 20.6 |  |  | $15.22 |  | — |  | (1) | $10.95 |  | 14.5 |  |  | $9.49
__________________ (1)Represents less than 0.1 million shares. (c) Share Repurchases During the three and nine months ended December 31, 2022 and 2021 the Company did not repurchase any common shares. To date, approximately $288.1 million common shares have been repurchased, leaving approximately $179.9 million of authorized potential repurchases.

X
- Definition Equity and Share-based Compensation [Abstract] + References No definition available. + Details
Name: | lgfa_EquityAndShareBasedCompensationAbstract
Namespace Prefix: | lgfa_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI https://asc.fasb.org/topic&trid=2208762 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI https://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration